Search the Site

Latest News

Amylyx Secures Series A Financing for Phase II Trial in ALS

August 23, 2016

Tackling Mutant C9ORF72 Transcripts at the Source

August 23, 2016

U.S. National ALS Registry Reports Updated ALS Prevalence Estimates

August 18, 2016

Neuroimaging Technique Tracks Epigenetic Changes in the Living Human Brain

August 18, 2016

Invitae Expands Its Diagnostic Tests for Neuromuscular and Neurodegenerative Diseases

August 18, 2016

Cytokinetics Completes Enrollment in Phase III Trial of Tirasemtiv in ALS

August 17, 2016

AxoSim Explores Nerve-On-A-Chip Technology for ALS, MS

August 12, 2016

NeuroBANK™ Program to be Expanded With Large Grant

August 10, 2016
All News »

Send us Feedback

Click here

Your Name (required)

Your Email (required)

Your Comment or Question

to send us a comment or suggestion.

To submit a proposed image for the banner, email
Funding Opportunities

Letter of intent due by August 31st. Target ALS Foundation Industry-Led Consortia
More information »

Letter of intent due by August 31st. Target ALS Foundation Young Investigator-Led Collaborative Projects
More information »

Letter of Intent due by September 1st. MDA Venture Philanthropy
More information »

More funding »
Upcoming Meetings

August 31-September 2, 2016: International Conference of Frontotemporal Dementias
More information »

September 7-9, 2016: Neurological Disorders Summit
More information »

September 12-13, 2016: A Workshop on Therapeutic Development for Nervous System Disorders in the Absence of Predictive Animal Models of Disease
More information »

September 12-15, 2016: CNS Diseases World Summit
More information »

September 12-14, 2016: European CNS Summit 2016
More information »

More meetings »
Share this: